Nuvectis Pharma's chart data is dated 2026-10-09. There is no active technical signal. There are 4 published signal records.
Nuvectis Pharma last closed at $21.12 (+4.92%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -17.8×. Its overall grade ranks 407 of 736 stocks in Healthcare.
About this company
Nuvectis Pharma last closed at $21.12 (+4.92%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 407/736
Valuation grade A
Related stocks
- AstraZenecaCompetitor
항암제 파이프라인을 보유한 글로벌 대형 제약사로, Nuvectis의 종양학 신약 개발과 같은 시장에서 경쟁 가능성이 큼
- Merck & Co.Competitor
면역항암제·표적항암제 중심의 글로벌 빅파마로 항암 분야 경쟁 기준점
- Bristol Myers SquibbCompetitor
종양학 분야에서 강한 포트폴리오를 가진 대형 제약사로, 항암 신약 개발 경쟁 상대
About Nuvectis Pharma
- What technical signals does Nuvectis Pharma (NVCT) have?
- Nuvectis Pharma current technical signals: no active technical signal.
- Is Nuvectis Pharma a cup-and-handle pattern?
- No. Nuvectis Pharma has no valid Cup signal right now.
- What published figures are available for Nuvectis Pharma?
- Market cap: $540.99M. Trailing 12 months PER: -17.8×. Latest quarter PBR: 54.59×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Nuvectis Pharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.